One of the scourges of hospital infections – biofilms formed by bacteria that stick to living tissue and medical instruments – can be tricked into dispersing with the targeted application of nanoparticles and heat.
The University of New South Wales study, jointly led by Associate Professor Cyrille Boyer of the School of Chemical Engineering and deputy director of Australian Centre for NanoMedicine, appears in today’s issue of Nature’s open access journal Scientific Reports.
“Chronic biofilm-based infections are often extremely resistant to antibiotics and many other conventional antimicrobial agents, and have a high capacity to evade the body’s immune system,” said Associate Professor Boyer. “Our study points to a pathway for the non-toxic dispersal of biofilms in infected tissue, while also greatly improving the effect of antibiotic therapies.”
Biofilms have been linked to 80% of infections, forming on living tissues (eg. respiratory, gastrointestinal and urinary tracts, oral cavities, eyes, ears, wounds, heart and cervix) or dwelling in medical devices (eg. dialysis catheters, prosthetic implants and contact lenses).
The formation of biofilms is a growing and costly problem in hospitals, creating infections that are more difficult to treat – leading to chronic inflammation, impaired wound healing, rapidly acquired antibiotic resistance and the spread of infectious embolisms in the bloodstream.
They also cause fouling and corrosion of wet surfaces, and the clogging of filtration membranes in sensitive equipment – even posing a threat to public health by acting as reservoirs of pathogens in distribution systems for drinking water.
In general, bacteria have two life forms during growth and proliferation: planktonic, where bacteria exist as single, independent cells; or aggregated together in colonies as biofilms, where bacteria grow in a slime-like polymer matrix that protects them from the environment around them.
Acute infections mostly involve planktonic bacteria, which are usually treatable with antibiotics. However, when bacteria have had enough time to form a biofilm – within a human host or non-living material such as dialysis catheters – an infection can often become untreatable and develop into a chronic state.
Although biofilms were first recognised in the 17th century, their importance was not realised until the 1990s, when it became clear that microbes exist in nature more often in colonies made up of lots of different microorganisms that adhere to surfaces through slime excreted by their inhabitants. Thus began a global race to understand biofilms, at a time when it was also realised they were responsible for the majority of chronic infections.
The discovery of how to dislodge biofilms by the UNSW Faculty of Engineering team – jointly led by Dr Nicolas Barraud, formerly of UNSW and now at France’s Institut Pasteur – was made using the opportunistic human pathogen Pseudomonas aeruginosa. This is a model organism whose response to the technique the researchers believe will apply to most other bacteria.
When biofilms want to colonise a new site, they disperse into individual cells, reducing the protective action of the biofilm. It is this process the UNSW team sought to trigger, making the bacteria again susceptible to antimicrobial agents.
Once dispersed, the bacteria are easier to deal with – creating the potential to remove recalcitrant, antimicrobial-tolerant biofilm infections.
The UNSW team found that by injecting iron oxide nanoparticles into the biofilms, and using an applied magnetic field to heat them – which induces local hyperthermia through raising the temperature by 5°C or more – the biofilms were triggered into dispersing.
The Latest on: Chronic bacterial infections
via Google News
The Latest on: Chronic bacterial infections
- Drug Resistance Developed By Bacteria In Cystic Fibrosis – Discoveredon February 28, 2021 at 10:06 am
Slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis have been discovered.
- The coronavirus jab's most tantalising side effects? It may help fight cancer, chronic pain... and even Alzheimer'son February 27, 2021 at 5:56 pm
Scientists have documented unexpected benefits of vaccines for decades - known medically as 'non-specific effects' - but explanations vary between experts.
- Eating raw vegetables may increase risk of stomach infection — Experton February 27, 2021 at 4:00 pm
A medical practitioner, Dr Elvis Igbinovia, speaks to ALEXANDER OKERE about H. pylori, a common bacterial infection of the stomach and its complicationswhat is H.pylori infection?pylori infection ...
- Popular hand soap facing recall over bacterial contamination concernson February 26, 2021 at 10:26 am
Hand soaps sold at retailers like Walmart are facing a recall over concerns that they are contaminated with potentially serious bacteria.
- Investigators still looking for source of outbreak of E. coli infections in Austriaon February 26, 2021 at 2:59 am
Austrian authorities are investigating an outbreak of Shiga toxin-producing E. coli (STEC) infections that has affected a handful of people. Between ...
- Antibiofilm activity of Fmoc-phenylalanine against Gram-positive and Gram-negative bacterial biofilmson February 26, 2021 at 1:23 am
Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon 2018;4:e01067. Algburi A, Comito N, Kashtanov D, Dicks LMT, Chikindas ML. Control of Biofilm ...
- Engineered viruses can fight the rise of antibiotic-resistant bacteriaon February 24, 2021 at 1:02 am
The threat of antibiotic-resistant bacteria has been growing for years and appears to be getting worse. If COVID-19 taught us one thing, it’s that governments should be prepared for more global public ...
- Antibiotic-free remedy aims to conquer bacterial vaginosison February 23, 2021 at 2:31 am
Ferring, Rebiotix and MyBiotics collaborate to develop live microbiome-based biotherapeutics in reproductive medicine and maternal health.
- Global HOSPITAL ACQUIRED INFECTIONS THERAPEUTIC Market Is Poised To Value Over USD 13.7 Billion By 2030on February 21, 2021 at 9:38 pm
The global Hospital Acquired Infections Therapeutic market size is expected to be worth around US$ 13.7 billion by 2030, according to a new report by Vision Research Reports. The global Hospital ...
- Chronic Inflammation: When too much of a good thing turns deadlyon February 21, 2021 at 1:39 pm
Chronic inflammatory diseases are the most significant cause of death in the world. The World Health Organization ranks chronic diseases as the greatest threat to human health.” ...
via Bing News